A Study to Test Whether Survodutide (BI 456906) Helps People Living With Overweight or Obesity Who Also Have Diabetes to Lose Weight

计划入组 755 人 · 首次发布于 2023 年 10 月 4 日

A Study in Healthy People to Compare How 2 Different Formulations of Survodutide Are Taken up by the Body

计划入组 100 人 · 首次发布于 2025 年 10 月 28 日

LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis

计划入组 1,590 人 · 首次发布于 2024 年 10 月 9 日

Survodutide

D&D Pharmatech's DD01 Shows Rapid Liver Fat Reduction in MASH Phase 2 Trial, Matching Competitor Results in Quarter of the Time

Survodutide Shows Promise in Obesity and MASH with Significant Weight and Blood Pressure Reduction

Boehringer Ingelheim Advances Dual-Action Obesity Drug Survodutide to Phase 3 Trials